Spravato (Esketamine)

Have you (or has someone you care about) been battling treatment-resistant depression?

We’re thrilled to announce that Sonder now offers a breakthrough treatment: Spravato (esketamine)
This innovative approach is:

• Safe and FDA-approved
• Effective with rapid results
• Administered in a comfortable outpatient setting
• Typically covered by most insurance plans
   

What is Spravato?

Spravato (esketamine) is an innovative, FDA-approved nasal spray designed for those suffering from treatment-resistant depression (TRD). Unlike traditional antidepressants, Spravato works by targeting glutamate receptors in the brain, potentially offering rapid relief from depression symptoms within hours.

Who is a good candidate for Spravato?

Spravato is ideal for adults with Major Depressive Disorder (MDD) who have not found relief with conventional antidepressants. Ideal candidates:

• Have been diagnosed with MDD.
• Have tried and not responded to at least two different antidepressant medications.
• Are open to a treatment plan that includes both Spravato and an oral antidepressant.

Is there proof Spravato can help?

Yes, numerous clinical studies have shown Spravato’s effectiveness. Key findings include:

• Over 50% of patients experience a significant reduction in depression symptoms.
• Many patients notice improvements within the first week of treatment.
   

These results highlight Spravato's potential to provide rapid and significant relief for those with chronic depression.

What is the typical treatment protocol?

Spravato treatment at Sonder involves a streamlined and supportive process:

1. Initial Assessment: Your first step will be a phone consultation with Mitch, our Spravato Coordinator. Mitch will gather necessary information and address any questions you may have. Following this, we’ll schedule an intake with a Spravato provider.
2. Administration: Spravato is self-administered as a nasal spray. After administering, you'll relax in our comfortable and private office space for 2 hours while the medication takes effect. During this time, you'll be closely monitored for safety.
3. Treatment Schedule: Initial treatments are typically administered twice a week for the first month, transitioning to weekly and then monthly sessions as needed.

What are potential side effects?

Most patients tolerate Spravato well, but some possible side effects include:

• Dissociation or feeling disconnected
• Dizziness
• Nausea
• Headache
• Increased blood pressure

Side effects are usually mild and temporary. We’ll monitor your experience closely to manage any issues promptly.

Does insurance cover Spravato?

Yes, if you qualify for Spravato through your medication management provider, most insurance companies will cover both the medication and its administration. At Sonder, we conduct a benefits investigation and provide a cost estimate before treatment begins. We also offer financing options and Spravato’s financial assistance program for eligible patients.

Is there a long waiting list?

Great news: Spravato services are currently offered at our Minnetonka location and we have immediate availability for new patients!

How do I get started?

Starting with Spravato is easy:

Fill out the form below, and Mitch, our Spravato Coordinator, will get in touch within 1 business day. (You can also email us at spravato@sonderwellness.com or call us at 952-999-6097, option 1.)